Lerut J, Stieber A C, Makowka L, Esquivel C O, Iwatsuki S, Gordon R D, Starzl T E
Helv Chir Acta. 1989 Aug;56(3):405-20.
During the cyclosporine era 1980-1984, 393 consecutive orthotopic liver transplantations (OLT) were performed in 313 patients at the University of Pittsburgh. This paper analyses the long-term results in this group of patients who have been followed-up for a minimum of three years. The results of OLT for different indications are discussed. The five-year survival rates after OLT for metabolic diseases, biliary atresia, primary biliary cirrhosis, posthepatic cirrhosis and primary hepatobiliary cancer are 75%, 68%, 60%, 58.9%, 53.2% and 23.8%, respectively. Recurrence of the primary disease after OLT is rare for benign diseases but rather frequent for malignant ones. The incidence of retransplantation for delayed rejection and for extrahepatic complications is discussed. The quality of life for most of the long-term survivors is good. Because of its good long-term results, OLT should become the therapy of choice in a lot of acute and chronic hepatopathies.
在1980 - 1984年的环孢素时代,匹兹堡大学为313例患者进行了393例连续原位肝移植(OLT)。本文分析了对这组患者进行至少三年随访后的长期结果。讨论了不同适应证的OLT结果。代谢性疾病、胆道闭锁、原发性胆汁性肝硬化、肝后性肝硬化和原发性肝胆癌患者OLT后的五年生存率分别为75%、68%、60%、58.9%、53.2%和23.8%。OLT后原发性疾病的复发在良性疾病中很少见,但在恶性疾病中相当常见。讨论了因延迟性排斥反应和肝外并发症而再次移植的发生率。大多数长期存活者的生活质量良好。由于其良好的长期效果,OLT应成为许多急慢性肝病的首选治疗方法。